Synonyms: compound 21 [PMID: 22985027] | dimethylaminomicheliolide
Compound class:
Synthetic organic
Comment: DMAMCL (dimethylaminomicheliolide) is a Michael adduct of micheliolide (a natural plant-derived guaianolide sesquiterpene lactone; PubChem CID 442279) [2]. It was originally identified for its ability to inhibit acute myelogenous leukemia (AML) stem and progenitor cells. More recently its mechanism of action has been determined [1]. It induces irreversible tetramerization of PKM2 and acts as a functional activator of PKM2 pyruvate kinase activity. This mechanism is being exploited as a potential anti-cancer therapeutic, with an orally active DMAMCL prodrug (ACT001) in early clinical trial (in Australian trial ACTRN12616000228482) in patients with advanced solid tumours, including glioblastoma multiforme (GBM).
|
|
No information available. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Low pyruvate kinase activity caused by the inactive dimeric state of PKM2 has been identified as a key mechanism for the proliferation of cancer cells within tumours. Stabilisation of PKM2 in its active tetrameric form by activators such as DMAMCL is predicted to provide clinical anti-tumour effects, based on in vitro and in vivo evidence [1-2]. |